Merck (MRK) Non Operating Interest Expenses (2011 - 2013)
Merck (MRK) recorded Non Operating Interest Expenses of $184 million in Q1 2013, up 5.1% from $175 million a year earlier but down 3.2% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Non Operating Interest Expenses (2011 - 2013) Analysis & Trends
On a TTM basis, Merck's Non Operating Interest Expenses came in at $724 million as of Mar 31, 2013, up 4.3% year-over-year; for FY2012, it came in at $714 million, up 2.7% from FY2011.
- Annual Non Operating Interest Expenses has a three-year compound annual growth rate of 15.8% (FY2009 to FY2012).
- Across earlier years, Non Operating Interest Expenses came in at $695 million in FY2011 (-2.8%), $715 million in FY2010 (+55.4%) and $460 million in FY2009.
- Quarterly Non Operating Interest Expenses has ranged from $170 million in Q2 2011 to $190 million in Q4 2012 over the past five years.
- On a year-over-year basis, Non Operating Interest Expenses has increased for four consecutive quarters, with growth averaging 2.3% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $190 million (Q4 2012), $178 million (Q3 2012) and $172 million (Q2 2012).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,333.71 Bn | 1,307.33 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.21 Bn | 585.07 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 521.27 Bn | 489.32 Bn | 13.12 Bn | - |
| 4 | Merck | 370.99 Bn | 325.42 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 314.75 Bn | 288.32 Bn | - | - |
| 6 | Astrazeneca | 293.18 Bn | 267.16 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 258.67 Bn | 214.07 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 216.53 Bn | 191.55 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 175.50 Bn | 123.16 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 139.19 Bn | 111.18 Bn | 2.91 Bn | 36.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 184.00 Mn |
| Dec 31, 2012 | 190.00 Mn |
| Sep 30, 2012 | 178.00 Mn |
| Jun 30, 2012 | 172.00 Mn |
| Mar 31, 2012 | 175.00 Mn |
| Dec 31, 2011 | 173.00 Mn |
| Sep 30, 2011 | 176.00 Mn |
| Jun 30, 2011 | 170.00 Mn |
| Mar 31, 2011 | 186.00 Mn |
API Access
Merck Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();